지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objectives Aripiprazole is an antipsychotic that functions as a partial agonist in hypodopaminergic states and a dopamine antagonist in hyperdopaminergic states. Methods This paper reports a series of five clinical cases of worsening psychotic symptoms in schizophrenic patients related to the initiation of aripiprazole, oral and injection, as combination therapy. Results In all five cases, the switching of aripiprazole improved the psychotic symptoms. Conclusion Even with the suggestive relationship between aripiprazole therapy and the worsening of psychotic symptoms, further research is needed.
목차
등록된 정보가 없습니다.
참고문헌 (9)
참고문헌 신청
DeLeon A / 2004 / Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability / Clin Ther 26:649~666
Lawler CP / 1999 / Interactions of the novel antipsychotic aripiprazole(OPC-14597)with dopamine and serotonin receptor subtypes / Neuropsychopharmacology 20:612~627
Marder SR / 2003 / Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials / Schizophr Res 61:123~136
Potkin SG / 2003 / Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder / Arch Gen Psychiatry 60:681~690
FDA Drug Safety Podcast: FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada) / fda.gov
Lawler CP / 1999 / Interactions of the novel antipsychotic aripiprazole(OPC-14597)with dopamine and serotonin receptor subtypes / Neuropsychopharmacology 20:612~627
Marder SR / 2003 / Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials / Schizophr Res 61:123~136
Potkin SG / 2003 / Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder / Arch Gen Psychiatry 60:681~690
FDA Drug Safety Podcast: FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada) / fda.gov
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Psychotic Symptoms in Patients With Major Neurological Diseases
Journal of Clinical Neurology
2024 .03
-
Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
Clinical Psychopharmacology and Neuroscience
2017 .01
-
A Case of Subacute Psychosis in a Patient With Germ Cell Tumor
생물치료정신의학
2023 .02
-
초발 정신병 삽화 환자와 정신건강의학과 의사 간의 치료 욕구에 대한 관점 차이 비교
생물치료정신의학
2018 .02
-
Psychotic Disorders and the Risk of Type 2 Diabetes Mellitus, Atherosclerotic Cardiovascular Diseases, and All-Cause Mortality: A Population-Based Matched Cohort Study
Diabetes and Metabolism Journal
2024 .01
-
Aripiprazole, a dopamine receptor D2 (D2R) partial agonist increases the sensitization to radiotherapy in head and neck cancer cells
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Aripiprazole-induced Hepatitis: A Case Report
Clinical Psychopharmacology and Neuroscience
2019 .01
-
Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea
Clinical Psychopharmacology and Neuroscience
2017 .01
-
정신질환자 범죄 증가의 원인과 대책
보건의료기술평가
2019 .01
-
Tardive Dystonia Related with Aripiprazole
PSYCHIATRY INVESTIGATION
2017 .01
-
First Manic Episode in a Young Woman with Schizophrenia after Initiation of Oral Aripiprazole and Aripiprazole Long-Acting Injection
우울조울병
2019 .01
-
‘2019 한국형 조현병 약물치료 지침서’에 따른 조현병에서 동반증상 및 부작용의 치료
대한조현병학회지
2019 .01
-
“Food for Thought”: Improving Cognition in People With Schizophrenia
PSYCHIATRY INVESTIGATION
2024 .08
-
노인 우울증 환자에서 Aripiprazole과 Bupropion 부가요법의 효과 및 안전성 비교 : 사후분석연구
생물치료정신의학
2019 .06
-
조현병 스펙트럼 환자에서 정신건강복지법에 의한 입원형태에 영향을 미치는 요인에 대한 분석
신경정신의학
2019 .01
-
Open channel block of Kv1.4 potassium channels by aripiprazole
The Korean Journal of Physiology & Pharmacology
2020 .01
-
The Potential Benefits of Aripiprazole : Focus on ASD and ADHD with Recent Clinical Study
대한소아청소년정신의학회 학술대회논문집
2020 .11
-
The potential benefits of Aripiprazole : Focus on ASD and ADHD with recent clinical study
대한소아청소년정신의학회 학술대회논문집
2019 .11
-
Intramuscular Aripiprazole in the Therapy of Acute Mania for More than 24 hrs
PSYCHIATRY INVESTIGATION
2019 .01
-
Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia
Clinical Psychopharmacology and Neuroscience
2023 .02
이 논문의 저자 정보
최근 본 자료
댓글(0)
0